Spiros Miyakis

Spiros Miyakis

Auto-generated profile, based on publicly available information

Spiros Miyakis

University of Wollongong

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SBStuart Bond
Stuart Bond
SCShelley P Crowther
Shelley P Crowther
SASuman Adhikari
Suman Adhikari
ACAdriana J Chubaty
Adriana J Chubaty
Ping YuPing Yu
Ping Yu
SMSpiros Miyakis
Spiros Miyakis
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

18 November 2024 in BMC Urology
Verified
Journal Article
Open access
PDF file
NKNarayan Khanal
Narayan Khanal
CCColin Cortie
Colin Cortie
CSChloe Story
Chloe Story
SJSandra Jones
Sandra Jones
Kylie J. MansfieldKylie J. Mansfield
Kylie J. Mansfield
CKCaitlin Keighley
Caitlin Keighley
Urinary tract infections (UTIs) are common however the widespread use of antibiotics has led to a rise in antimicrobial resistance (AMR) amongst uropathogens, rendering a significant proportion of infections resistant to first line treatment. AMR in UTIs may differentially affect men and women, younger and older patients. The purpose of this study was to investigate MDR (multi-drug resistance) and AMR in males and females in an Australian health district. There were 85,844 E. coli urinary isolates (2007–2020) analysed from adult patients. An E. coli isolate with MDR was defined as resistant to at least 1 agent in ≥ 3 antimicrobial classes. Chi-square tests and relative risk were calculated by comparing resistance in males and females and by age for antibiotics commonly used to treat UTIs in hospital and community collected samples. There was a higher proportion of MDR E. coli in males compared to females in both the community (6.4% vs. 5.2%, P < 0.001) and hospital datasets (16.5% vs. 12.8%, P < 0.001). The proportions of MDR for both males and females were significantly higher in the hospital setting. Resistance rates were higher in males compared to females for amoxicillin, amoxicillin/clavulanate, cephalexin and norfloxacin (p < 0.005), though not for trimethoprim. Antibiotic resistance was seen to increase over time. A higher proportion of MDR E. coli were noted in urine samples from males compared with females, possibly due to the increased likelihood of prior treatment for UTIs in men. Antimicrobial stewardship interventions could be targeted towards this cohort to address increasing rates of AMR.

26 February 2018 in JMIR Medical Education
Verified
Journal Article
Open access
SBStuart Bond
Stuart Bond
SCShelley P Crowther
Shelley P Crowther
SASuman Adhikari
Suman Adhikari
ACAdriana J Chubaty
Adriana J Chubaty
Ping YuPing Yu
Ping Yu
SMSpiros Miyakis
Spiros Miyakis
A New Peer-Reviewed Journal with Focus on Technology, Innovation and Openess in Medical Education

14 July 2022 in Journal of Hospital Infection
Verified
Journal Article
Closed access
SMS. Miyakis
S. Miyakis
SBS. Brentnall
S. Brentnall
MMM. Masso
M. Masso
GRG. Reynolds
G. Reynolds
MBM.K. Byrne
M.K. Byrne
AOA.M. van Oijen
A.M. van Oijen

25 February 2025 in Antibiotics
Verified
Journal Article
Open access
PDF file
Chloé SmitChloé Smit
Chloé Smit
CKCaitlin Keighley
Caitlin Keighley
KRKris Rogers
Kris Rogers
SMSpiros Miyakis
Spiros Miyakis
KTKatja Taxis
Katja Taxis
Lisa PontLisa Pont
Lisa Pont
Background: Antimicrobial resistance (AMR) is a global health challenge with significant global variation. Little is known about the prevalence on a smaller geographical scale. Objectives: This study aimed to explore the geo-temporal variation in antibiotic resistance in Escherichia coli (E. coli) urinary isolates in the Illawarra Shoalhaven region, a region south of Sydney. Methods: Data from urine E. coli isolates from people living in the community were geospatially analysed from 2008 to 2018. The proportion of resistant isolates was mapped by antibiotic type (amoxicillin with clavulanic acid, cefalexin, norfloxacin, and trimethoprim), postcode, and year. Results: Resistance varied by antibiotic, postcode, and over time, with some postcodes showing increased resistance one year and a decrease the following year. Areas with consistently higher resistance included metropolitan, port, and lake regions. We found low resistance in E. coli to amoxicillin with clavulanate, cefalexin, and norfloxacin (<5% to 10–19%) and the highest resistance for trimethoprim (10–19% to 30–39%). Overall, from 2008 to 2018, E. coli resistance to all four antibiotics increased in this region. Conclusions: This study shows temporal and geospatial changes in E. coli AMR over small geospatial areas, indicating the opportunity for geospatial analysis to assist in area-specific empirical treatment guidance.

1 December 2004 in Clinica Chimica Acta
Verified
Journal Article
Open access
SMSpiros Miyakis
Spiros Miyakis
PGPetros Georgakopoulos
Petros Georgakopoulos
MKMaria Kiagia
Maria Kiagia
OPOlga Papadopoulou
Olga Papadopoulou
APAggelos Pefanis
Aggelos Pefanis
TMTheodoros D. Mountokalakis
Theodoros D. Mountokalakis